CoaguSafe - Anticoagulant
Girard Development GmbH Medical iPhoneiPadiPod touch
CoaguSafe - Anticoagulant is a paid Medical app for iPhone and iPad by Girard Development GmbH. Rated 4.6/5 from 15 ratings. Requires iOS 14.0.
- Rating
- 4.6
- 15 ratings
- Price
- 2.99 USD
- on the App Store
- Size
- 5 MB
- Age 17+
- Updated
- Apr 20
- 2026 · v4.7
Screenshots
About CoaguSafe - Anticoagulant
Please note: CoaguSafe is not a substitute for medical advice. CoaguSafe is intended for educational purposes only. Puzzled by the vast amount of medication interacting with platelet function and coagulation? When do they have to be paused for surgery or anesthesia ? This app gives you an answer to these questions and is therefore an ideal educational tool. The covered substances are: - Oral anticoagulants - Heparin - Low molecular weight heparin - Adenosin diphosphate (ADP) antagonists - Factor Xa inhibitors - Thrombin inhibitors - Cyclooxygenase inhibitors - Gp IIb/IIIa inhibitors The following guidelines can be selected: - University Hospital Basel, Switzerland - Kantonsspital St. Gallen, Switzeralnd - Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI) - Österreichische Gesellschaft für Anästhesiologie, Reanimation und Intensivmedizin - European Society of Anaesthesiology (ESA) The American Society of Regional Anesthesia (ASRA) guidelines had to be removed in July 2024 at the behest of ASARA. Local recommendations and expert opinion of the following hospitals were used to develop this app: University Basel, Switzerland Work done by: - Miodrag Filipovic - Manfred Seeberger - Michael Zellweger Kantonsspital St. Gallen, Switzerland Work done by: - Miodrag Filipovic - Wolfgang Korte - Hans Rickli CoaguSafe was programmed by Thierry Girard in collaboration with and under expert consulting by Miodrag Filipovic. --------- Disclaimer --------- The application CoaguSafe is not a substitute for medical advice. CoaguSafe is intended for educational purposes only. While the data may be updated periodically, users should independently check medical literature and package inserts or other sources for the latest information. Any and all liability arising directly or indirectly from the use of this application is hereby disclaimed. The information herein is provided "as is" and without any warranty expressed or implied. All direct, indirect, special, incidental, consequential or punitive damages arising from any use of this application or data contained herein is disclaimed and excluded.
Ratings & reviews
4.6
15 ratings
What’s new
Version 4.7 · Updated April 20, 2026
NOTE: The American Society of Regional Anesthesia (ASRA) guidelines had to be removed in July 2024 at the behest of ASARA. (before giving me a low review consider that ASRA (and their attorneys) see a copy right infringement in using a published guideline) Guidelines from the University Hospital of Basel, Switzerland have been added and the Austrian Guidleines updated.
App privacy
The developer, Girard Development GmbH, reported these privacy practices to Apple.
Data Not Collected
The developer does not collect any data from this app.
Alternatives to CoaguSafe - Anticoagulant
Looking for apps like CoaguSafe - Anticoagulant? Here are 6 similar apps on the App Store. The highest rated is Magnet Master (4.9/5), and 4 of the 6 are free to download.
-
Magnet Master
4.9
-
Anesthesia One
4.8
-
Anesthesia Dose Assistant
2.3
-
Coexisting Diseases & Surgery
4.6
-
NYSORA Ultrasound Pain
4.8
-
Anesthesia Central
4.6
| App | Rating | Price | Last updated | Compare |
|---|---|---|---|---|
| CoaguSafe - Anticoagulant | 4.6 / 5 (15 ratings) | 2.99 USD | April 20, 2026 | |
| Magnet Master | 4.9 / 5 (112) | 4.99 USD | Aug 11, 2026 | Compare |
| Anesthesia One | 4.8 / 5 (6) | Free | Jul 30, 2026 | Compare |
| Anesthesia Dose Assistant | 2.3 / 5 (3) | Free | Jul 10, 2026 | Compare |
| Coexisting Diseases & Surgery | 4.6 / 5 (29) | 99.99 USD | Aug 5, 2026 | Compare |
| NYSORA Ultrasound Pain | 4.8 / 5 (112) | Free | Sep 17, 2026 | Compare |
| Anesthesia Central | 4.6 / 5 (105) | Free | May 6, 2026 | Compare |